RecallDepth
Class II Ongoing

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30

This recall is currently active, issued June 26, 2024. It was issued by Eugia Us Llc.

Company
Eugia Us Llc
Recall Initiated
May 23, 2024
Posted
June 26, 2024
Recall Number
D-0555-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
70,125 vials
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

Distribution

USA Nationwide

Lot / Code Info

Lot#: 3DS23001, 3DS23004, Exp 6/30/2024; 3DS23009, 3DS23011, Exp 7/31/2024

More recalls by Eugia Us Llc

View all recalls by this company →

Other recent Class II Drug recalls